AIMS

June 25, 2021
AIMS, Academic Research

Matt Alteen is used to convincing people that sugars do more than we once thought. While most of us associate carbohydrates strictly with diet and nutrition, scientists like Alteen are working to show that these natural compounds have a much broader […]

Read Article
May 19, 2021
AIMS, Academic Research

At the Drugs for Neglected Diseases initiative (DNDi), Ben Perry has an enviable position. A medicinal chemist by training, Perry now works with leading pharmaceutical companies and academic labs around the world. He also gets to try the latest […]

Read Article
May 14, 2021
Events, AIMS, Academic Research

At the American Association for Cancer Research Annual Meeting 2021, the abstract for the research program between Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center, Ursulain College, and Atomwise […]

Read Article
May 13, 2021
AIMS, Academic Research

With as many as 2 million people dying each year from tuberculosis, there’s a crying need for better treatment options. Current therapy regimens involve a long and complicated combination of several drugs that many patients never complete, leading […]

Read Article
March 30, 2021
AIMS, Academic Research

Since the 2003 discovery that the PCSK9 protein played a key role in regulating metabolism of low-density lipoprotein (LDL), pharmaceutical companies have poured resources into targeting it for cholesterol management. There has been some success […]

Read Article
February 17, 2021
AIMS, Academic Research, Joint Ventures

Long before SARS-CoV-2 triggered the worst pandemic most of us have ever experienced, Nito Panganiban was concerned about the ability of RNA viruses to leap from animal reservoirs into the human population. In the past century, there have been more […]

Read Article
January 22, 2021
AIMS, Academic Research

While outcomes for breast cancer patients have steadily improved over the years, one particularly vexing type known as triple-negative breast cancer (TNBC) has continued to defy those rosy trends. One of the challenges in treating TNBC is that it […]

Read Article
November 04, 2020
AIMS, Academic Research

Jeffrey MacKeigan is not your traditional academic scientist. After completing his postdoctoral fellowship, he spent two years at one of the largest pharmaceutical companies in the world. That gives him a unique perspective on how academic labs, […]

Read Article
October 28, 2020
AIMS, Academic Research, Featured

It’s not unusual for scientists to be discouraged by a lack of treatment options for their disease of interest. There is, however, a special kind of frustration for researchers who have clearly identified a promising biological target for treating […]

Read Article
Pages: 1 2 »

Subscribe

Stay up to date on new blog posts.

Atomwise needs the contact information you provide to send you updates. You may unsubscribe from these communications at any time. For information please review our Privacy Policy.